NCT07092462

Brief Summary

In recent years, the widespread use of social media and digital platforms has led to the emergence of behavioural patterns such as doomscrolling, which involves the compulsive consumption of negative or distressing online content. This can often lead to increased anxiety and psychological distress. While this phenomenon has been studied extensively in the general population, its impact on individuals with chronic pain conditions, particularly fibromyalgia, remains largely unexplored. FM is a complex disorder characterised by widespread musculoskeletal pain, fatigue, sleep disturbances and cognitive difficulties, often accompanied by heightened emotional distress. As FM patients often experience anxiety and depression and engage in maladaptive coping strategies, doomscrolling may exacerbate their symptoms and impair their overall well-being. Existing research suggests that excessive social media use is linked to social media addiction (SMA), fear of missing out (FoMO) and poor sleep quality - all of which are particularly relevant to FM patients, who already struggle with sleep dysfunction and psychosocial challenges. Nevertheless, no investigation heretofore has specifically scrutinised the association between doomscrolling, SMA, FoMO and fibromyalgia-related disability. Understanding these associations could provide valuable insights into how digital behaviours influence FM symptomatology and help to identify potential intervention targets to mitigate negative outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
173

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 29, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

August 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

2 months

First QC Date

July 21, 2025

Last Update Submit

November 23, 2025

Conditions

Keywords

fibromaylgiadoomscrollingsleep disturbancesquality of life

Outcome Measures

Primary Outcomes (3)

  • Doomscrolling Scale

    Sharma et al. developed the Doomscrolling Scale to measure the extent to which participants scroll through persistently negative information on social media. Satıcı et al. conducted a study to create a Turkish version of the scale. The scale consists of 15 items. It is a 7-point Likert scale, where 1 equals strongly disagree and 7 equals strongly agree. High scores imply high levels of doomscrolling. In this study, the scale will be used with adults.

    Baseline

  • Bergen Social Media Addiction Scale

    The Bergen Social Media Addiction Scale (BSMAS) will be used by the researchers to assess social media addiction. The BSMAS comprises six items. Each item is rated on a scale from one (very rarely) to five (very often). The items will be used to calculate the scores, with higher numbers indicating a higher degree of social media addiction. Demirci (2019) conducted the Turkish adaptation of the BSMAS used in this study. Demirci deemed the uni-dimensional structure of the Turkish BSMAS to be acceptable.

    Baseline

  • Fibromyalgia Impact Questionnaire (FIQ)

    The Fibromyalgia Impact Questionnaire (FIQ) is a tool designed to assess and evaluate the status, progress and outcomes of individuals living with fibromyalgia (FM). It takes approximately five minutes to complete the FIQ, which is a self-administered instrument. The instructions are straightforward and the scoring is self-explanatory. The FIQ comprises 10 items. A 4-point Likert scale is used to rate the 11 questions in the first item, which are all related to physical functioning. Scores range from 0, indicating no impairment, to 10, indicating maximum impairment.

    Baseline

Secondary Outcomes (2)

  • Fear of Missing Out Scale (FOMOS)

    Baseline

  • The Pittsburgh Sleep Quality Index (PSQI)

    Baseline

Study Arms (2)

Fibromyalgia patients

individuals suffering from fibromyalgia

Healthy subjects

healthy subjects will be matched with controls demographically (age, gender and education).

Eligibility Criteria

Age18 Years - 49 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

* The sample will consist of patients diagnosed with "Fibromyalgia" who are under the follow-up of Uşak Training and Research Hospital, Department of Physical Medicine and Rehabilitation. * A small control group of 50 participants will be included in the study. To minimise confounding factors, healthy subjects will be matched with controls demographically (age, gender and education).

You may qualify if:

  • Being within the 18-49 age group (based on date of birth).
  • Not practising any regular sport or exercise.
  • Not having any chronic health problems or physical disabilities.
  • Volunteering to participate in the study.

You may not qualify if:

  • The presence of diagnosed neurological diseases that may adversely affect quality of life (similar to MS or migraine).
  • The presence of diagnosed psychiatric diseases that may adversely affect quality of life (similar to depression or OCD).
  • The presence of diagnosed rheumatological diseases that may adversely affect quality of life (e.g. rheumatoid arthritis or ankylosing spondylitis).
  • Not using a smartphone as part of one's lifestyle (i.e. not using applications).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Usak University

Uşak, 64200, Turkey (Türkiye)

Location

Related Publications (1)

  • Can G, Satici SA. Adaptation of fear of missing out scale (FoMOs): Turkish version validity and reliability study. Psicol Reflex Crit. 2019 Jan 22;32(1):3. doi: 10.1186/s41155-019-0117-4.

MeSH Terms

Conditions

FibromyalgiaInternet Addiction DisorderParasomnias

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesTechnology AddictionBehavior, AddictiveCompulsive BehaviorImpulsive BehaviorBehaviorSleep Wake DisordersMental Disorders

Study Officials

  • Ender Salbas, asst. proff.

    Balikesir University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 21, 2025

First Posted

July 29, 2025

Study Start

August 1, 2025

Primary Completion

September 15, 2025

Study Completion

October 1, 2025

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Research data supporting this publication are available upon request from the authors. The datasets generated and/or analyzed during the current study are available from the corresponding author

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
After the study was published
Access Criteria
If the study is published in a journal, then the data will be open

Locations